Morselizing Copolymer Joint Depot for Synovial Drug Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively deliver pharmaceutically active principles to synovial and other joint tissues, leading to inadequate retention and modulation of drug release, necessitating a formulation that can target and morselize these tissues for prolonged drug delivery.
Innovation Solution
A biodegradable drug delivery composition comprising a triblock and diblock copolymer, administered to joints, undergoes morselization due to mechanical challenges, breaking into smaller pieces to enhance retention and targeted delivery of pharmaceutically active principles to synovial tissues.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional drug delivery methods are used, then administration is simple, but retention and targeted delivery to synovial tissues is inadequate
Solution Approach 1:
The patent employs composite polymer materials consisting of triblock and diblock copolymers with specific polyester and polyethylene glycol components. These composite materials provide enhanced retention and targeted delivery to synovial tissues through their biodegradable properties and mechanical challenges that promote morselization, directly resolving the contradiction between reliable delivery and formulation complexity
Solution Approach 2:
The drug delivery composition is segmented into morsels through mechanical challenges in the joint environment. This segmentation allows the formulation to maintain simplicity in administration while achieving reliable retention and targeted delivery through the progressive breakdown into smaller pieces that can penetrate and persist in synovial tissues
2Duration of action of moving object
If drug delivery composition is administered as-is, then administration is simple, but release rate modulation is inadequate
Solution Approach 1:
The formulation dynamically responds to mechanical challenges in the joint environment, transitioning from an intact state to morselized pieces over time. This dynamic behavior enables prolonged duration of action for drug delivery while maintaining ease of manufacture, as the morselization process occurs automatically upon administration without requiring complex preparation steps
3Reliability
If the formulation undergoes morselization, then retention and targeted delivery are enhanced, but the formulation structure becomes more complex
Solution Approach 1:
The formulation is designed to undergo controlled segmentation into morsels through mechanical challenges. This segmentation enhances retention by allowing the drug-containing pieces to penetrate and persist in synovial tissues, while the underlying polymer structure remains stable and well-defined, thus resolving the contradiction between retention enhancement and structural stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves prolonged retention and targeted delivery of active principles to synovial tissues, modulating release rates and providing effective treatment for joint conditions.
Implementation Method 1
a biodegradable drug delivery composition comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and one end-capped polyethylene glycol
Implementation Method 2
undergoes morselization due to mechanical challenges, breaking into smaller pieces to enhance retention and targeted delivery
Data Source
AI summary
A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.


